Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02675907 · ClinicalTrials.gov registry record · Phase 3
Evaluation of N1539 Following Bunionectomy Surgery
A Phase 3 study of Pain, Post Operative, sponsored by Baudax Bio.
- Completed
- Registry status
- Phase 3
- Development phase
- 201
- Enrollment target
- 4
- Study locations
NCT02675907 is a Phase 3 study of Pain, Post Operative that has completed, run by Baudax Bio. The registered enrollment target is 201 participants, below the 300-participant average among 4 other Pain, Post Operative trials with a reported enrollment target (33% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT02675907, a Phase 3 study of Pain, Post Operative, has completed, sponsored by Baudax Bio.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 201 participants
- Enrollment target
- 4
- Study locations
Study Summary
The primary objective of this study is to evaluate the analgesic efficacy of N1539 in subjects with acute moderate to severe pain following unilateral bunionectomy.
Conditions Studied
Interventions
- DRUG Intravenous Placebo
- DRUG N1539
Study Locations (4)
California
- Trovare Clinical Research - Bakersfield
- Lotus Clinical Research - Pasadena
Maryland
- Chesapeake Research Group - Pasadena
Texas
- Endeavor Clinical Trials - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02675907
The ClinicalTrials.gov registry entry for NCT02675907 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 300-participant average among 4 other Pain, Post Operative trials with a reported enrollment target (33% lower). The listed sponsor is Baudax Bio, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain, Post Operative appearing as the primary indexed condition, and to 2 interventions - of which Intravenous Placebo is the first listed.
NCT02675907 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT02675907 about?
NCT02675907 is a clinical study titled "Evaluation of N1539 Following Bunionectomy Surgery". The primary objective of this study is to evaluate the analgesic efficacy of N1539 in subjects with acute moderate to severe pain following unilateral bunionectomy.
What is the current status of trial NCT02675907?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 201 participants. The study started on 2016-01. Estimated completion is 2016-07.
What conditions does trial NCT02675907 study?
This clinical trial studies the following conditions: Pain, Post Operative.
What interventions are being tested in trial NCT02675907?
The interventions under investigation include: Intravenous Placebo (DRUG), N1539 (DRUG).
Who is sponsoring clinical trial NCT02675907?
This trial is sponsored by Baudax Bio, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02675907 being conducted?
This trial has 4 study locations across California, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Post Operative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial
RECRUITING · Phase 4
-
Music Therapy in the Treatment of Perioperative Anxiety and Pain
COMPLETED · NA
-
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.